Researchers create experimental vaccine against Alzheimer's

October 8, 2010

Researchers at UT Southwestern Medical Center have created an experimental vaccine against beta-amyloid, the small protein that forms plaques in the brain and is believed to contribute to the development of Alzheimer's disease.

Compared with similar so-called DNA vaccines that the UT Southwestern researchers tested in an animal study, the new stimulated more than 10 times as many that bind to and eliminate beta-amyloid. The results appeared in the journal Vaccine.

Future studies will focus on determining the safety of the vaccine and whether it protects mental function in animals, said Dr. Roger Rosenberg, director of the Center at UT Southwestern and senior author of the study.

"The antibody is specific; it binds to plaque in the brain. It doesn't bind to that does not contain ," Dr. Rosenberg said. "This approach shows promise in generating enough antibodies to be useful clinically in treating patients."

A traditional vaccine – an injection of beta-amyloid itself into the arm – has been shown in other research to trigger an immune response, including the production of antibodies and other bodily defenses against beta-amyloid. However, the immune response to this type of vaccine sometimes caused significant brain swelling, so Dr. Rosenberg and his colleagues focused on developing a nontraditional DNA vaccine.

The DNA vaccine does not contain beta-amyloid itself but instead a piece of the beta-amyloid gene that codes for the protein. In the current study, the researchers coated tiny gold beads with the beta-amyloid DNA and injected them into the skin of the animals' ears. Once in the body, the DNA stimulated an immune response, including antibodies to beta-amyloid.

The next step in the research is to test long-term safety in animals, Dr. Rosenberg said.

"After seven years developing this vaccine, we are hopeful it will not show any significant toxicity, and that we will be able to develop it for human use," he said.

Related Stories

Recommended for you

Link between cells associated with aging and bone loss

August 21, 2017
Mayo Clinic researchers have reported a causal link between senescent cells - the cells associated with aging and age-related disease - and bone loss in mice. Targeting these cells led to an increase in bone mass and strength. ...

Make way for hemoglobin

August 18, 2017
Every cell in the body, whether skin or muscle or brain, starts out as a generic cell that acquires its unique characteristics after undergoing a process of specialization. Nowhere is this process more dramatic than it is ...

Bio-inspired materials give boost to regenerative medicine

August 18, 2017
What if one day, we could teach our bodies to self-heal like a lizard's tail, and make severe injury or disease no more threatening than a paper cut?

Are stem cells the link between bacteria and cancer?

August 17, 2017
Gastric carcinoma is one of the most common causes of cancer-related deaths, primarily because most patients present at an advanced stage of the disease. The main cause of this cancer is the bacterium Helicobacter pylori, ...

Two-step process leads to cell immortalization and cancer

August 17, 2017
A mutation that helps make cells immortal is critical to the development of a tumor, but new research at the University of California, Berkeley suggests that becoming immortal is a more complicated process than originally ...

New Pathology Atlas maps genes in cancer to accelerate progress in personalized medicine

August 17, 2017
A new Pathology Atlas is launched today with an analysis of all human genes in all major cancers showing the consequence of their corresponding protein levels for overall patient survival. The difference in expression patterns ...

4 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

axemaster
not rated yet Oct 08, 2010
Uh, having the immune system attack brain cells and structures in the brain, be they harmful or not, sounds risky to me... Then again I don't know much about the subject, so...

Good luck to the researchers!
hypermach
not rated yet Oct 08, 2010
I would volunteer in a heartbeat
DaffyDuck
5 / 5 (1) Oct 09, 2010
Trials of drugs designed to target and clear amyloid plaques haven't worked well so I kind of doubt this will either. I saw a recent study showing that brain cells create amyloid to get rid of oxidative iron but fail to do so because excess zinc blocks the action so the cells keep pumping out amyloid. Another study showed that Alzheimer's patients have high levels of iron in the brain. Not sure if iron is the main cause of cell death in the brain but it seems plausible if in fact iron is the main reason for the creation of amyloid proteins then it stands to reason that oxidative iron is unwanted.
tkjtkj
not rated yet Oct 10, 2010
Trials of drugs designed to target and clear amyloid plaques haven't worked well so I kind of doubt this will either.


Your logic would be a tremendous force to cease all research unless it's known that the result of the research will be successful!
My, my. Let me assure you that oftentimes research fails to show a benefit to society merely because the particular study did not address a previously-unrecognized feature of the problem at hand. Even an issue concerning the species of the test animals could be crucially important. Mice are not people, and white mice are not black mice.

j.a., md

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.